RecruitingNCT03877575

Lyon Uveitis Study


Sponsor

Hospices Civils de Lyon

Enrollment

750 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

Uveitis or inflammation of the uveal tract results from a heterogeneous collection of disorders of varying etiologies and pathogenic mechanisms. Uveitis is relatively frequent in industrial countries with an estimation of 115 cases for 100 000 persons and is associated with a blindness risk of 10%. Causes of uveitis can be related to different etiologies (infectious, inflammatory or general inflammatory diseases). Therapeutic care is based on ophthalmologic and systemic diagnosis and treatment strategy depends on the severity of inflammation. The main objective of the Lyon uveitis study is to analyze the uveitis ophthalmologic etiology and diagnostic and therapeutic care of the patients. This study is proposed to all patients diagnosed for uveitis and referred to the Department of Internal Medicine of the Croix Rousse hospital, Lyon, france for etiologic diagnosis or treatment. Analysis of i) patients' characteristics, ii) the relevance of complementary exams to determine the uveitis etiology, iii) treatment used. This study will allow a better characterization of the disease on diagnosis practices and therapeutic care.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This French observational registry is collecting long-term data on patients with uveitis — inflammation inside the eye — to better understand what causes it, how it is diagnosed, and what treatments work best. Uveitis can lead to blindness in about 10% of affected people, and causes range from infections to inflammatory and autoimmune conditions. Any patient diagnosed with uveitis who is attending their first appointment at the Department of Internal Medicine at the Croix-Rousse Hospital in Lyon, France, for diagnosis or treatment is eligible to enroll. Participation involves sharing medical records, test results, and treatment details at clinic visits over time — there are no experimental treatments or additional procedures required. This summary was prepared with AI assistance to help patients understand the study in plain language.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo specific intervention. Collection of clinical data

Locations(1)

Department of Internal Medicine, Croix-Rousse Hospital, Hospices Civils de Lyon

Lyon, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03877575


Related Trials